Hemoglobin A1c Testing Devices Market to Reach US$1.8 bn by 2019 owing to Rising Diabetes Prevalence Health Articles | April 8 Cheap Vans Old Skool , 2016
Transparency Market Research Report Added "Hemoglobin A1c Testing Devices Market - Global Industry Analysis, Size, Trends and Forecast 2013 - 2019"
Hemoglobin A1c is a hemoglobin test that primarily identifies the three-month average plasma glucose concentration. This test also helps in determining the type of diabetes and then gauge how well a person is managing diabetes. Hemoglobin A1c is also known by many other names, such as glycosylated hemoglobin Cheap Old Skool Shoes , HbA1c, and glycated hemoglobin. The hemoglobin A1c test calculates the average of the blood sugar control over the previous 2 to 3 months and is used to make alterations in the dosage of diabetes medicines. Thus, most medical experts are recommending the use of these devices, which give precise results and help in monitoring blood sugar levels effectively Cheap Old Skool Suede , for diabetic patients.
Get Free Sample Research Report:
Increasing Prevalence of Diabetes to Boost Sales of Hemoglobin A1c Testing Devices Worldwide
According to a research study by Transparency Market Research, in 2012, the global hemoglobin A1c testing devices market was valued at US$0.9 bn and is estimated to reach a value of US$1.9 bn by the end of 2019. The market is projected to register a significant 10.30% CAGR between 2013 and 2019.
The tremendously rising number of diabetic patients, rising geriatric population Cheap Old Skool Leather , and proven benefits of hemoglobin A1c testing are some of the major factors that are expected to boost the demand for hemoglobin A1c testing devices globally in the next few years. In addition, the lucrative market opportunities in several developing nations and rapid commercialization of these devices for diagnosis of diabetes are some of the opportunities for the players operating in the global market for hemoglobin A1c testing devices.
On the flip side, the presence of viable substitutes and high costs of the test are the restraining factors that are projected to curb the growth of the market in the near future.
Point-of-care Testing Devices Segment to Register High Growth Rate between 2013 and 2019
The global market for hemoglobin A1c testing devices can be classified on the basis of application into point-of-care testing devices and laboratory testing devices. In 2012, the laboratory testing devices segment dominated the market Cheap Old Skool Pro , accounting for a 66.2% share in the overall hemoglobin A1c testing devices market. This segment is estimated to remain in the leading position in the next few years; nevertheless, the point-of-care testing devices segment is also expected to witness a high growth rate in the same period.
Furthermore, on the basis of technology, the global market for hemoglobin A1c testing devices can be divided into:
Ion-exchange HPLC Boronate Affinity Chromatography Immunoassay Direct Enzymatic Assay Others (such as Micro-Optical Detection and Capillary Electrophoresis)
In 2012 Cheap Old Skool Mens , the ion-exchange HPCL segment led the global market. However, the boronate affinity chromatography segment is anticipated to register the highest growth rate in the coming years.
Full Research Report on Global Hemoglobin A1c Testing Devices Market:
A "Life Settlement" is a lump sum settlement paid to the owner of a life insurance policy by one of many funding sources in exchange for the ownership of the policy. Never before have non-terminal policyholders been able to receive capital in excess of their policy's cash or surrender value to increase their wealth. A Life Settlement can usually provide anywhere from 2 to 5 times the cash surrender value of the policy. "With the life settlement option availble, there is no reason to surrender or lapse your life insurance policy." says Grant Shellhammer, of > Generally Cheap Vans Old Skool Shoes , anyone over age 70 who has $100,000 or more in life insurance coverage may qualify for a Life Settlement regardless of health condition. Other factors considered in the negotiations are the policy's cash surrender values and the cost of premiums. A basic principle to remember is that the older the age of the insured andor the more health complications exist, the higher the settlement. However, each individual's situation is different from case to case.
The fundamentals of the Life Settlement transaction have technically been around since 1989 in the form of "viatical settlements". Individuals at any age can qualify for a viatical settlement if they have a chronic or terminal illness such as cancer or HIV. Viatical Settlements have always been contingent upon the health of the insured Cheap Vans Old Skool Suede , whereas Life Settlements are contingent mainly upon the age of the insured. In most states a terminally ill senior applicant will need to use a licensed viatical broker andor funder in order to abide by state rules and regulations and to retain the tax-exempt status of the settlement.
According to industry reports, Life Settlement proceeds are tax-free up to the cost basis (premiums paid since policy inception). They are taxed as ordinary income from basis to cash surrender value and proceeds above the cash surrender value are taxed as capital gains.